Should I Feel IontoPatch or ACTIVApatch Working? Iontophoresis Sensation, Dexamethasone Blanching & Troubleshooting

If you are using an IontoPatch or ACTIVApatch iontophoresis patch and do not feel electrical stimulation, that is usually expected.

In contrast to a TENS unit or NMES muscle stimulator, an iontophoresis patch is designed not to produce a strong buzzing sensation or visible muscle contraction. These patches use a very low electrical current delivered over a comparatively long period to help transport a prescribed ionized medication through intact skin.

Many patients therefore feel minimal sensation while the patch is operating normally. Some people notice a faint tingling, tugging, or pulling sensation, but feeling electrical stimulation is not required for the treatment to be occurring. The IontoPatch manufacturer specifically states that there is typically no sensation during normal operation, although occasional slight tingling or tugging can occur.

That distinction is one of the most important things to understand about wearable iontophoresis.

Why Don't I Feel the Iontophoresis Current?

Wearable iontophoresis systems such as IontoPATCH STAT, 80 & Extra Strength and ACTIVApatch IntelliDose, IontoGo 4.0 & IontoGo 12.0 deliberately spread the electrical dose over hours rather than delivering it during a short clinic session.

Electrical iontophoresis dose is typically expressed in milliampere-minutes, or mA·min:

Electrical dose = current × treatment time

This means the same overall electrical dose can be delivered with a relatively higher current for a shorter period or a much lower current over a longer period.

For example, IontoPATCH STAT and IontoPATCH 80 both provide an 80 mA·min electrical dose, but STAT averages about four hours of wear, while IontoPATCH 80 averages approximately 14 hours. Balego describes IontoPATCH 80 as the slower, lower-current delivery option.

ACTIVApatch follows the same general principle. Current models provide an 80 mA·min treatment over approximately 2.5, 4, or 12 hours depending on the selected model.

Why extended delivery can feel like nothing

Using the labeled electrical dose and nominal treatment time illustrates the principle:

*These figures are simple dose ÷ nominal-time calculations intended only to illustrate why the stimulation may be difficult to perceive. They are not manufacturer-specified constant-output settings. Actual current flow can vary with skin resistance, patch design, contact, hydration, and treatment conditions.

By comparison, conventional controller-based iontophoresis may use currents measured in whole milliamperes over a much shorter treatment period.

The wearable format can therefore deliver the prescribed electrical dose without producing the obvious electrical sensation many patients associate with TENS or clinic-based stimulation.

No Sensation Does Not Mean the Patch Is Not Working

This is an important point:

You should not use sensation as your test of whether an IontoPatch or ACTIVApatch is operating.

Research on iontophoresis shows that sensation depends substantially on current density, treatment area, skin resistance, and individual sensitivity. Tingling and itching become more noticeable as current density increases, while lower-current delivery is generally better tolerated.

For an extended-wear patch, the absence of tingling can therefore be entirely compatible with normal operation.

How Do I Know My IontoPatch Is Working?

The original IontoPatch models do not operate like an electronic stimulator with an LCD screen, intensity knob, audible beep, or treatment light.

The patch incorporates its own electrical power system. Once the prescribed medication and conductive solution have been correctly prepared and the reservoirs establish proper contact with the skin, the electrical circuit begins operating. Balego's application guidance explains that current begins when the properly prepared medication and saline chambers make secure skin contact.

For IontoPatch:

• Do not wait for tingling before assuming treatment has started.
• Do not increase medication or modify the patch to try to "feel" it.
• Follow the prescribed model and fill volume.
• Keep the entire patch securely attached.
• Follow the clinician-provided removal time.
• Do not extend treatment simply because you never felt electrical stimulation.

Our detailed IontoPatch FAQ covers model selection, wear times, normal sensations, removal, and common patient questions without duplicating those instructions here.

How do I know if the ACTIVApatch is working?

The answer depends on which ACTIVApatch model you have.

ACTIVApatch IntelliDose 2.5

The IntelliDose 2.5 has an advantage when a patient is concerned that they cannot feel the treatment: it incorporates SmartPower LED feedback.

According to the manufacturer, after activation the LED provides information about patch status and skin resistance. During normal delivery, the LED flashing pattern confirms that skin impedance is within an acceptable range and current flow has begun. If resistance is too high, the unit displays a different flash sequence.

So with IntelliDose:

Trust the status indicator—not whether you can feel the electricity.

ACTIVApatch IontoGo 4.0 and IontoGo 12.0

The IontoGo 4.0 and 12.0 are also self-powered wearable iontophoresis patches, but they do not use the same SmartPower LED feedback system as IntelliDose.

They incorporate SHUNT automatic shutoff technology, which ends the treatment after the intended 80 mA·min electrical dose has been delivered.

Again, a lack of sensation by itself does not indicate treatment failure.

What Should I Normally Feel During Iontophoresis?

Patient experiences vary.

Usually compatible with normal treatment

• No electrical sensation at all
• Very mild tingling
• A faint pulling or tugging sensation
• Awareness that an adhesive patch is attached
• Mild temporary redness after removal
• In some patients using dexamethasone, localized temporary skin blanching

Not something to simply ignore

• Strong burning
• Sharp or stabbing pain
• Increasing stinging
• Significant swelling
• Blistering
• Open or broken skin
• A burn-like lesion
• Spreading rash or hives
• Severe itching
• Facial, lip, tongue, or throat swelling
• Trouble breathing

Iontophoresis is generally well tolerated, but skin irritation is the most commonly reported local adverse effect. The medical literature describes erythema, tingling, burning, and temporary discomfort, with the potential for burns when current density or other treatment conditions become inappropriate.

If you experience significant burning, pain, or an abnormal skin reaction, remove the patch according to its instructions and contact the treating healthcare professional.

We have a separate irritation, burning, and removal guide for those situations.

Why Can Dexamethasone Cause the Skin to Turn White?

This is an especially relevant question because skin blanching can look alarming if the patient is not expecting it.

When dexamethasone sodium phosphate has been prescribed for iontophoresis, a patient may notice a localized area of paler or temporarily whitened skin beneath or around the medication reservoir.

This can be related to a known pharmacologic property of corticosteroids:

Corticosteroids can constrict superficial blood vessels.

Dexamethasone is a glucocorticoid corticosteroid. Corticosteroids can cause cutaneous vasoconstriction, meaning superficial blood vessels narrow and less blood is visible through the skin.

That decrease in visible cutaneous blood flow can produce the appearance known as blanching.

This phenomenon is so well established that the skin-blanching or vasoconstrictor assay has historically been used to evaluate the activity of topical corticosteroids. A review of the technique explains that local vasoconstriction and the associated reduction in blood flow in the skin’s microvasculature are believed to account for the blanching response.

A controlled human study examining several corticosteroids specifically reported that dexamethasone produced visible skin blanching.

Dexamethasone iontophoresis has also been associated with cutaneous vasoconstriction.

This finding is particularly relevant to iontophoresis.

In a study examining dexamethasone/dexamethasone-phosphate delivery by iontophoresis, researchers used the appearance of cutaneous vasoconstriction in human subjects as evidence that dexamethasone had been delivered to at least the depth of the superficial vasculature.

Other research has demonstrated that iontophoresis can increase the delivery of dexamethasone sodium phosphate into human skin and underlying connective tissues compared with passive delivery.

Therefore:

A localized, temporary pale or blanched area beneath the dexamethasone medication side of an iontophoresis patch can be consistent with dexamethasone's known vasoconstrictive effect.

It does not automatically mean that the skin has been burned or damaged.

Is Dexamethasone Blanching Proof That the Patch Worked?

No.

Blanching can support a plausible pharmacologic explanation, but it should not be used as a required indicator of successful iontophoresis.

Some patients may blanch noticeably.

Others may show very little visible change.

Factors that influence blanching include:

• medication concentration;
• time of exposure;
• individual corticosteroid sensitivity;
• anatomical location;
• skin pigmentation;
• skin thickness;
• local circulation; and
• treatment conditions.

The corticosteroid blanching literature demonstrates substantial individual and site-to-site variability.

Therefore:

Absence of sensation does not indicate patch failure, and absence of blanching does not indicate medication delivery failure.

Dexamethasone Blanching vs. Skin Irritation: How Can You Tell the Difference?

The appearance alone cannot always establish the cause, but the overall pattern is helpful.

Temporary blanching may be expected with dexamethasone.

Why Dexamethasone Is Commonly Discussed With Iontophoresis

Dexamethasone sodium phosphate is one of the most frequently described medications in musculoskeletal iontophoresis literature.

The phosphate formulation is water soluble and negatively charged under commonly used conditions, making it suitable for electrically assisted transdermal transport. Experimental research has shown that cathodal iontophoresis increases dexamethasone-phosphate transport and deposition within skin compared with passive application.

However, this result does not mean dexamethasone is appropriate for every injury or every patient.

The prescribing or treating healthcare professional must determine medication selection, formulation, concentration, polarity, dose, treatment frequency, and treatment site.

Neither IontoPatch nor ACTIVApatch is sold as a premedicated dexamethasone patch.

For clinicians who want a deeper review of drug polarity and published iontophoresis literature, we maintain a separate Iontophoresis Medication and Polarity Guide.

Quick Troubleshooting: "I Activated the Patch but Feel Nothing"

If the only concern is "I don't feel anything," that by itself is generally reassuring rather than concerning.

Check the following instead:

1. Confirm the exact patch model.

Determine whether you have:

• IontoPATCH STAT
• IontoPATCH 80
• IontoPatch Extra Strength
• ACTIVApatch IntelliDose 2.5
• ACTIVApatch IontoGo 4.0
• ACTIVApatch IontoGo 12.0

Each model has a different treatment profile.

2. Confirm that the patch was prepared according to its instructions.

Do not improvise medication volume, polarity, reservoir selection, hydration, or activation.

IontoPatch and ACTIVApatch do not use identical preparation methods.

For example, current IontoPatch models use medication in the appropriately charged reservoir and saline in the opposite chamber, while ACTIVApatch uses its own hydrogel dispersive-electrode design.

3. Make sure the patch has full skin contact.

Poor contact can interfere with predictable current flow.

The treatment site should be prepared according to the specific manufacturer's instructions, and the adhesive should remain secure around the patch.

4. Do not use sensation as the endpoint.

You do not need to "feel it kick in."

Follow the prescribed treatment duration or the product's status system.

5. If using IntelliDose, check the LED.

The IntelliDose SmartPower indicator provides more useful information about operating status than subjective sensation.

6. Watch the skin—but interpret changes appropriately.

Mild temporary redness can occur.

If dexamethasone has been prescribed, a localized pale or blanched area can occur because of corticosteroid-induced vasoconstriction.

Neither reaction should become significantly painful, blistered, or progressively worse.

Frequently Asked Questions

Should I feel IontoPatch working?

Usually not. The manufacturer states that there is typically little or no sensation during normal IontoPatch operation. Some patients experience a faint tingling or tugging sensation.

Should I feel ACTIVApatch working?

Not necessarily. ACTIVApatch uses a low-voltage current delivered over several hours. Treatment should not be judged solely by whether electrical stimulation can be felt. IntelliDose users can use its SmartPower LED feedback to assess operating status.

Why doesn't an iontophoresis patch feel like TENS?

TENS is designed to stimulate sensory nerves and commonly produces a noticeable tingling sensation. Iontophoresis uses direct electrical current primarily to assist the transport of an ionized medication through the skin. The treatment goals and electrical characteristics are different.

Does no tingling mean the medication isn't being delivered?

No. Absence of sensation is common with low-current extended-wear patches and does not by itself indicate treatment failure.

Is white skin under a dexamethasone patch normal?

Localized temporary blanching can occur because dexamethasone and other corticosteroids can cause cutaneous vasoconstriction. Dexamethasone-induced visible blanching has been demonstrated experimentally, and vasoconstriction has also been observed after dexamethasone iontophoresis.

How long should dexamethasone blanching last?

There is no universal time because response varies with the patient, treatment site, drug exposure, and other factors. Color should generally trend back toward the patient's baseline after treatment. Persistent, painful, worsening, blistered, or otherwise abnormal discoloration should be evaluated by the treating professional rather than assumed to be a harmless steroid response.

Is redness after iontophoresis normal?

Mild temporary redness can occur from the direct current, adhesive, moisture, pressure, medication, or skin contact. Significant pain, blistering, progressive irritation, or spreading reactions are not considered routine treatment effects.

Should I increase the medication if I cannot feel the patch?

No. Never change medication concentration or volume in an attempt to create a stronger sensation. Medication, concentration, polarity, treatment dose, and patch selection must follow the prescriber's and manufacturer's instructions.

Bottom Line

If you activate an IontoPatch or ACTIVApatch and do not feel electrical current, that can be completely consistent with normal operation.

These wearable iontophoresis patches intentionally deliver relatively low electrical current over an extended period. They are not designed to feel like TENS, and they do not need to produce tingling for iontophoresis to take place.

Some people feel:

• nothing at all;
• faint tingling;
• a mild tugging sensation; or
• simple awareness of the adhesive.

When dexamethasone sodium phosphate has been prescribed, a temporary pale or blanched area beneath the medication side can also occur. Dexamethasone is a corticosteroid with a documented cutaneous vasoconstrictive effect, and published iontophoresis research has observed cutaneous vasoconstriction following dexamethasone delivery.

The important distinction is between painless, temporary blanching and an abnormal skin reaction.

Strong burning, sharp or worsening pain, blistering, open skin, marked swelling, persistent abnormal discoloration, spreading rash, or other significant symptoms should not be treated as normal simply because iontophoresis is being used.

For product-specific information, compare IontoPatch STAT, 80, and Extra Strength with ACTIVApatch IntelliDose, IontoGo 4.0, and IontoGo 12.0, or browse our Iontophoresis collection.

Clinical-use note: Iontophoresis involves the transdermal delivery of medication. The medication, formulation, concentration, polarity, treatment site, electrical dose, patch model, frequency, and treatment course should be determined by an appropriately qualified healthcare professional.